MINI REVIEW article
Front. Epigenet. Epigenom.
Sec. Epigenetics and Metabolism
Volume 3 - 2025 | doi: 10.3389/freae.2025.1699969
This article is part of the Research TopicEpigenetics and Metabolism: A Closed Liaison in Tumor CellsView all articles
Non-Coding RNAs at the intersection of epigenetics and cancer metabolism
Provisionally accepted- 1New York University Department of Neuroscience and Physiology, New York, United States
- 2Department of Human Science and Promotion of Quality of Life, San Raffaele Telematic University, Rome, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Cancer cells are primarily characterized by uncontrolled proliferation, which is closely linked to an increased energy demand. According to this, cancer cells preferentially utilize the glycolytic pathway for energy production. Metabolic regulation in cancer occurs at multiple levels, including post-translational modifications, which are rapid and energy-efficient, as they do not require enzyme degradation. In this context, non-coding RNA-mediated control plays a crucial role, as these small RNAs can directly modulate the mRNAs of key metabolic enzymes or induce epigenetic modulations, ultimately inducing alterations in cancer metabolism. In this mini-review, we summarize how non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), modulate core metabolic pathways, including glycolysis, mitochondrial respiration, lipid metabolism, and amino acid biosynthesis, in cancer. We also highlight recent findings that uncover novel regulatory mechanisms and propose that ncRNAs serve as dynamic integrators of metabolic and oncogenic signals. Understanding these interactions may open new avenues for biomarker identification and ncRNAs-targeted therapies development.
Keywords: ncRNA1, metabolic reprogramming2, circRNAs3, microRNA4, lncRNA5
Received: 05 Sep 2025; Accepted: 10 Oct 2025.
Copyright: © 2025 Mangraviti and Castelli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Serena Castelli, serena.castelli@uniroma5.it
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.